emerpand 9.5mg/24 hr transdermal patch
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - rivastigmine - transdermal patch - rivastigmine 9.5 mg/24 h - psychoanaleptics
emerpand 13.3mg/24hr transdermal patch
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - rivastigmine - transdermal patch - rivastigmine 13.3 mg/24 h - psychoanaleptics
exelon patch 10
novartis israel ltd - rivastigmine - patches - rivastigmine 9.5 mg/day - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.
exelon patch 15
novartis israel ltd - rivastigmine - patches - rivastigmine 27 mg - rivastigmine - exelon patch is indicated for the treatment of dementia of the alzheimr’s type (ad).efficacy has been demonstrated in patients with mild, moderate and severe alzheimer’s disease.
exelon patch 5
novartis israel ltd - rivastigmine - patches - rivastigmine 4.6 mg/day - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.
rivastigmine dexcel 1.5 mg
dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.
rivastigmine dexcel 3 mg
dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.
rivastigmine dexcel 4.5 mg
dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.
rivastigmine dexcel 6 mg
dexcel ltd, israel - rivastigmine as hydrogen tartrate - hard capsule - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementiaassociated with parkinson's disease.
rivastigmine sandoz transdermal patch 13.3mg/24hours
sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - rivastigmine - transdermal patch - rivastigmine 13.3 mg/24 h - psychoanaleptics